All News

25% of SLE and RA patients at this academic practice were receiving HCQ above recommended doses, by @SkorupaTara & @RobShmerling #ACR19 @rheumnow #Abstr #ACRBest https://t.co/pq379l9ZPH

Holy smokes! 18x higher risk of cardiovascular disease in Black SLE patients, highest at 1 and 10 years after diagnosis - Dr Shivani Garg #ACR19 @rheumnow #Abstr #ACRBest https://t.co/kXoMNu4QKb

A second study (after MAINRITSAN) showing the superiority of rituximab vs. azathioprine for maintenance of remission in ANCA-associated vasculitis, by Dr. Rona Smith #ACR19 @rheumnow #Abstr #ACRBest https://t.co/H8VJiFhp6z

GCA is really a chronic disease, difficult to maintain remission off meds, regardless of initial treatment strategy. Findings from Part 2 of the GIACTA trial of tocilizumab for GCA. Dr. John Stone #ACR19 @rheumnow #Abstr #ACRBest https://t.co/gxdQrH0pUj

BeSt for Kids study showed comparable efficacy of sequential monotherapy, MTX+pred, or MTX+Etanercept. However, many patients had TNFi added or TNFi switched to achieve inactive disease #ACR19 @rheumnow #Abstr #ACRBest https://t.co/p5xdJznNhN

Amazing! Most patients with systemic JIA who receive anakinra as first line monotherapy achieved drug-free remission. Dr Ravelli #ACR19 @rheumnow #Abstr #ACRBest https://t.co/cWUdUo6dmM

Systemic JIA may be a biphasic disease with early autoinflammatory phenotype and later autoimmune features. Dr. Ravelli #ACR19 @rheumnow #Abstr #ACRBest https://t.co/CsZeBOqeRH

Interesting to see worldwide differences is JIA subtypes and ages of onset. Dr Ravelli #ACR19 @rheumnow #Abstr #ACRBest https://t.co/MdrPTmixw9

New Eurofever / PRINTO criteria for #autoinflammatory diseases. Dr. Ravelli #ACR19 @rheumnow #Abstr #ACRBest https://t.co/S35Ltegz1F

Cool view of the immune system as a spectrum from immunodeficiency to autoimmunity. Dr Binstadt #ACR19 @rheumnow #Abstr #ACRBest https://t.co/b77LA9HbHQ

A wall of donuts. That is the best thing I’ve seen at #ACR19 https://t.co/GS6WntpCFc

The Knowledge Bowl...One of my favorite sessions of every Annual Meeting! #ACR19 https://t.co/p8aArZFbZe

Members of all species are enjoying #ACR19! @rheumnow #Abstr #ACRBest https://t.co/rYYsTcDEKe

The MS score helps diagnose MAS in patients with systemic JIA. Dr. Francesca Minoia #ACR19 @rheumnow #Abstr #ACRBest https://t.co/TO4EORxn5v

Health-related Social Media Use by Parents of Children with Rheumatic Diseases https://t.co/3L2fQ9vS8X https://t.co/3hfa3b5CdL

Health-related Social Media Use by Parents of Children with Rheumatic Diseases…

Online interactions translated into real-world behavior changes regarding their child’s heath. https://t.co/8iUW4OOpFq

How to distinguish Behcet's from haploinsufficiency 20 (HA20), a new autoinflammatory disease with recurrent oral ulcers. #ACR19 https://t.co/k0MTxJ1e6i

"The irresistible force meets the immovable object." The best lecture subtitle by none other than Dr. Dan Kastner from NIH. #ACR19 @RheumNow

Coming to a @nature issue near you: Cleavage-Resistant RIPK1-Induced Autoinflammatory (CRIA) Syndrome, the newest autoinflammatory disease in the block, by Dr. Dan Kastner. #ACR19 @RheumNow https://t.co/AISfoY0Zed

Excellent tag-team discussion of autoinflammatory diseases by Drs. Dan Kastner and @AmandaOmbrello. #ACR19 https://t.co/Zgq34F8CAx

Topics

All News

Do you get our email newsletter?